Kapruvia Európai Unió - izlandi - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - Öll önnur lækningavörur - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Tybost Európai Unió - izlandi - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Removab Európai Unió - izlandi - EMA (European Medicines Agency)

removab

neovii biotech gmbh - catumaxomab - ascites; cancer - Önnur æxlishemjandi lyf - removab er ætlað til að meðhöndla illkynja öndunarfærasjúkdóma hjá sjúklingum með epcam jákvæða krabbamein þar sem hefðbundin meðferð er ekki tiltæk eða ekki lengur unnt.

Maxalt Smelt Frostþurrkuð tafla 10 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

maxalt smelt frostþurrkuð tafla 10 mg

n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg

Maxidex Augndropar, dreifa 1 mg/ml Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

maxidex augndropar, dreifa 1 mg/ml

novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml